The report last year that a research team in China used CRISPR-Cas9 to modify non-viable human zygotes touched off a storm of controversy, but Nature News reports that new gene-editing studies are now going ahead with less fuss.
...and receive Daily News bulletins.
Already have an account?Login Now.
Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.
The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.
In Science this week: genetic overlap among many psychiatric disorders, and more.
The Economist writes that an increasing number of scientific journals don't do peer review.